Loading stock data…
Hyperfine, Inc. (HYPR)
$0.95+0.00 (+0.01%)
Market ClosedLast close Jul 24
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Hyperfine, Inc. in the Healthcare sector is trading at $0.95 with a market capitalization of $148M. Wall Street consensus targets $2.17 (3 analysts), implying a +127.1% move over the next 12 months. The stock is currently near its 52-week low of $0.85, remaining 23.1% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 14 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +127.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 14) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.90M↓ | $5.29M↑ | $3.44M↑ | $2.70M↑ | $2.14M |
| Gross Profit | $1.98M↓ | $2.69M↑ | $1.85M↑ | $1.33M↑ | $883,000 |
| Operating Income | -$8.56M↓ | -$7.67M↑ | -$8.92M↑ | -$9.60M↑ | -$10.90M |
| Net Income | -$8.62M↓ | -$5.91M↑ | -$11.02M↓ | -$9.22M↑ | -$9.42M |
Peer Comparison
JNJUNHPFE
Fundamentals
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$147.91M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-101.22%
Volume
Today's trading volume
302,384
Recent News
Hyperfine launches next-generation Swoop MRI system in Europe
The introduction of Model 2 into Europe aims to support Hyperfine’s international commercial objectives.
Hyperfine shares rise after expected Russell index addition (HYPR)
Shares of Hyperfine (NASDAQ:HYPR) gained 4% in premarket trading on Tuesday after the company announced that it is expected to be added to both the Russell 3000 Index and the Russell 2000 Index. Russell inclusion set to take effect after June reconstitutionThe medical technology company said its inclusion is expected to occur as part of the June 2026 Russell index reconstitution process, based on a preliminary list published by FTSE Russell on May 22, 2026.
Hyperfine Inc (HYPR) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Advances ...
Hyperfine Inc (HYPR) reports an 83% revenue increase and international expansion, but faces net losses and cash burn concerns.
Hyperfine Q1 Earnings Call Highlights
Hyperfine (NASDAQ:HYPR) reported a sharp year-over-year increase in first-quarter revenue and reiterated its full-year 2026 outlook, as management pointed to continued adoption of its next-generation Swoop portable MRI system across hospitals, neurology offices and international markets. President
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates
Hyperfine (HYPR) delivered earnings and revenue surprises of 0.00% and +14.12%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?